希腊的糖尿病和糖尿病前期患病率。第一届全国发病率和风险因素调查（EMENO）研究结果。

Prevalence of diabetes and pre-diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study.

机构信息

Hellenic Diabetes Association, Athens, Greece; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Department of Hygiene, Epidemiology & Medical Statistics, National and Kapodistrian University of Athens Medical School, Athens, Greece.

出版信息

Diabetes Res Clin Pract. 2021 Feb;172:108646. doi: 10.1016/j.diabres.2020.108646. Epub 2020 Dec 24.

DOI:10.1016/j.diabres.2020.108646

PMID:33359752

Abstract

AIMS

To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre-diabetes in Greece.

METHODS

Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided.

RESULTS

A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%).

CONCLUSIONS

This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management.

摘要

目的

报告希腊首次全国健康体检调查（HES）中糖尿病的患病率、药物治疗和控制水平以及糖尿病前期的结果。

方法

数据来源于全国发病率和危险因素调查（EMENO），该调查采用随机抽样方法，对希腊成年人群进行了代表性抽样。采用抽样权重调整研究设计，采用后分层权重使样本的年龄/性别分布与人口相匹配。通过逆概率加权法调整无应答情况。提供了加权患病率估计值。

结果

共纳入 4393 名接受 HbA1c 和/或空腹血浆葡萄糖检测的患者。总糖尿病患病率为 11.9%（95%CI：10.9-12.9），已知糖尿病为 10.4%（9.5-11.4），未知糖尿病为 1.5%（1.1-1.9），随着年龄组的增加而显著增加，且性别之间无差异。糖尿病前期患病率为 12.4%（11.4-13.6）。大多数已知糖尿病患者正在服用二甲双胍。在已知糖尿病患者中（并检测了 HbA1c），70.9%的患者得到了良好的控制（HbA1c<7.0%）。